You may be right...you may be wrong....I trust that current management will make the best decision based on facts as they exist. Also doubt that they have not learned some things since June financing. Conditions, knowledge, relationships always in flux...the nature of life.
Imagining that they are working on things other than simply issuing additional shares at this low price...that's where partnerships and borrowing against IP is mentioned. Wouldn't assume that further dilution is a given in any sense.
Hope your positive outlook is rewarded! Lots of questions reading between the lines:
Do they have enough $ to pursue Psoriasis treatment "on their own"?...or are they looking for partner that they might also "offer up" another treatment condition as enticement for $.
Phase 2 for Psoriasis doesn't begin in their current timeline until Q3 2016...that's alot of time from now unless they expect $ coming in from other sources. Hope they don't have to dilute more at only $1 or less per share.
BTW, I am a major believer and shareholder.
Why haven't they updated their Pipeline to reflect current plans?...or do they have other pursuits that are part of selling their patents/IP for treatment of other conditions that is also outlined in the presentation?
Hoping they have more than Psoriasis news to share re: results from Phase 1. Interesting that they still show "psoriasis" as the shortest bar on their web site with respect to Pipeline progress.
Just watched and listened to recorded version. (you can for free via registration)...link available from IWSY twitter, etc. Anyway, it was a fantastic presentation and should be required listening for IWSY investors. Frankly, good to hear someone other than just Jim Miller from IWSY...Harding definitely real world and impressive. Seems to be a really good partnership with Validsoft. I took some notes...but Opus moderator commented that they had a "packed house" for the presentation.
Carp, fyi, was glad to hear heavy emphasis on speed and scale and having a frictionless user experience. I learned quite a bit...and feel better about my investment here every day! Our time is coming!
Great! Also, curious to understand how IWSY may be contemplated for "in store" purchases in retail as well. Omnichannel commerce and user experience all the rage in retail. That is, providing consumer with seemless experience regardless of purchase channel. Makes me wonder if pilot referenced by Miller in last CC with Fujitsu and major Korean retailer may involve mobile as well as in-store use. See below for transcript sentence from cc:
"And Fujitsu has a number of pilots being run by large and well-known companies, which are customers of theirs including a major Korean retailer."
Carp, what you are saying all makes alot of sense to me. Think fingerprint becomes a very non-obtrusive way to confirm ID...perhaps in combination with another mode when/where the application requires it....say for instance only when transaction exceeds some minimum threshold.
Wonder if they might announce prelim results of Phase 1 PRIOR TO upcoming mid-Sep Conferences to generate further interest in their meetings/presentations.
Carp, thanks much. Yes, the "frictionless" part including speed has been one of my biggest worries in terms of adoption. If they have that part down, including having "low False Reject Rate" and hopefully nonexistent "False Accept Rate" that will certainly greatly enhance chances for this to be HUGE winner. Of course, I also suppose the ability to swap in/out various bio algorythms and types and IWSY open-ness there, is one of the big differentiators. So that's a plus as well.
Was glad to see this line:
"The authentication process, which
involves a consumer’s mobile device, typically takes
a second." ...and also the line about the Database being able to handle Cloud matching of 200Million transactions in real time.
Lots of "in memory" options being pushed by vendors these days. Wonder how open IWSY is to using various Databases and/or in-memory technologies or is the database somewhat proprietary to IWSY?
Agree. It's almost a joke to me that analysts could/would even change their estimates based on anything that has been publicly revealed, including Monday's call. Miller made it clear that any one of the balls in the air has potential to take them to cash flow positive in one of the months prior to end of calendar year. Yep, eventually they are going to have to "come through". At that point, might very well be a LANDSLIDE...and I hope/pray that these guys will/are protected from being taken out at a too low price. I didn't wait 10 years to see a 50-100% gain!...don't think Miller did either.
you can get free transcript of call on Seeking Alpha. It's already posted. Re: Major Retailer he said IWSY is ready to re-engage whenever Major Retailer is. He commented that Mexican privacy laws much more strict than US and only delay was caused by Major Retailer caution due to this. Basically, sounds like it is on hold until Major Retailer decides to proceed. Believe his estimate of 2016 revenues was in reference to what is required to be breakeven...believe he is bullish beyond this.
So far as encouraging as it can be without realized revenue report! "Lockheed vetted our product over several years...and it is bundled in, NOT an option". GREAT. Also, reiterated cash flow positive by end of calendar year...at least in certain months...(they can't do that without new revenue)
I think a big formula for success NEEDS to be partner bundling IWS offering into their solution...not as an option...but requirement for access to the solution. Pure speculation, but primary solution provider is reluctant to make this a MUST rather than an option because competitors have not done so. Again, who takes responsibility for losses when/if they happen...if it is the primary solution provider, they should be simply bundling IWS offering into their solution without calling it out as an option.
Likely, I agree. That said, I would like to think that these guys have worked with enough scientists in "high places" to take an interest in the potential of their findings...even if they still have some way to go before fully proven out. My biggest fear now is that the thing that necessitated the "optional part 2 of Phase 1" may result in further delay and/or complexities for the progress moving forward. They must be sitting on something though given the lengths that they have taken to remain "alive" and commit to the go forward payouts to all of the cronies that have screwed up and/or are just looking to line their own pockets. They have been rather amateurish in terms of execution....I was hoping the amateurs were largely gone but then we have the latest issue with the stock raise not meeting requirements...
Who are you talking about?...this is not a particularly large company, so why don't you be more specific if you have valuable information to share? Chuck Aubuchon, I believe, has been with the company a long time and was responsible for Business Development, at least by title. Are you saying he is gone? And/or are you referring to Jeff Harris, SVP, who I believe was hired within the last year and was supposed to be responsible for sales. Are you saying he is gone?